Notably, components of the EGF signaling network, Adam10, a metallopeptidase that processes EGF, and Grb2, an adaptor protein that binds directly to the EGF receptor, exhibited a greater importance for transgenic than for tumor TFs (Figure 7, blue dots). This evidence concerns the gene GRB2 and neoplasm.